Literature DB >> 15571932

IL-10 production in B cells is confined to CD154+ cells in patients with systemic lupus erythematosus.

Andrea Díaz-Alderete1, José C Crispin, María Inés Vargas-Rojas, Jorge Alcocer-Varela.   

Abstract

The immunological hallmark of SLE is B cell hyperactivity. CD154 (CD40-L) is normally expressed in activated T cells, and plays an important role in T-B interactions. Its expression is increased in SLE T cells. Additionally, its expression on B cells leads to the development of SLE-like disease in a transgenic model. IL-10 is a key cytokine in the disturbed SLE immune system. The aim of this work was to explore the relation between IL-10 and CD154 expression in SLE B cells. We studied 11 SLE patients and 10 healthy volunteers. Mononuclear cells were isolated from peripheral blood and cultured in the presence or absence of Cowan I Strain Staphylococcus (CSS). Surface CD154 and intracytoplasmic IL-10 expression were quantified with flow cytometry. In basal conditions, CD154 expression was not different in patients and controls. B cell stimulation did not cause a significant increase in CD154 expression in control B cells. However, its expression increased 2 times in B cells obtained from SLE patients. IL-10 expression was confined to CD154(+) cells. Our results show that IL-10 production is intimately linked to CD154 expression in B cells, and that the IL-10(+)CD154(+) B cell subset increases abnormally when SLE-derived cells are stimulated with CSS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571932     DOI: 10.1016/j.jaut.2004.10.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  9 in total

1.  Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Authors:  Yohei Iwata; Takashi Matsushita; Mayuka Horikawa; David J Dilillo; Koichi Yanaba; Guglielmo M Venturi; Paul M Szabolcs; Steven H Bernstein; Cynthia M Magro; Armistead D Williams; Russell P Hall; E William St Clair; Thomas F Tedder
Journal:  Blood       Date:  2010-10-20       Impact factor: 22.113

Review 2.  Autoimmunity and Cancer-Two Sides of the Same Coin.

Authors:  Justyna Sakowska; Łukasz Arcimowicz; Martyna Jankowiak; Ines Papak; Aleksandra Markiewicz; Katarzyna Dziubek; Małgorzata Kurkowiak; Sachin Kote; Karolina Kaźmierczak-Siedlecka; Karol Połom; Natalia Marek-Trzonkowska; Piotr Trzonkowski
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

Review 3.  The multi-faceted influences of estrogen on lymphocytes: toward novel immuno-interventions strategies for autoimmunity management.

Authors:  Ebru Karpuzoglu; Moncef Zouali
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

Review 4.  The Role of Regulatory B cells in Kidney Diseases.

Authors:  Wang Long; Hedong Zhang; Wenjia Yuan; Gongbin Lan; Zhi Lin; Longkai Peng; Helong Dai
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

5.  Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus.

Authors:  Yihong Yao; Brandon W Higgs; Chris Morehouse; Melissa de Los Reyes; Wendy Trigona; Philip Brohawn; Wendy White; Jianliang Zhang; Barbara White; Anthony J Coyle; Peter A Kiener; Bahija Jallal
Journal:  Hum Genomics Proteomics       Date:  2009-11-17

6.  IL-10 is predominantly produced by CD19(low)CD5(+) regulatory B cell subpopulation: characterisation of CD19 (high) and CD19(low) subpopulations of CD5(+) B cells.

Authors:  Jae Ho Lee; Joonyong Noh; Geunwoong Noh; Wahn Soo Choi; Sang Sun Lee
Journal:  Yonsei Med J       Date:  2011-09       Impact factor: 2.759

7.  B Cells with Regulatory Function in Human Diseases.

Authors:  Yuhua Wang; Xiaozhe Han
Journal:  Autoimmune Dis Ther Approaches       Date:  2014-12-22

Review 8.  The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells.

Authors:  Jialing Liu; Qiuli Liu; Xiaoyong Chen
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

9.  Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus Erythematosus patients: a focus on B cells.

Authors:  Mitra Abbasifard; Zahra Kamiab; Mohammad Hasani; Amir Rahnama; Pooya Saeed-Askari; Hossein Khorramdelazad
Journal:  BMC Immunol       Date:  2020-11-16       Impact factor: 3.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.